Management of post-prandial hyperglycemia of diabetic patients by acting on glucose transporters such as SGLT-1 [14] or GLUT2 in this present paper could represent a real opportunity, first to decrease glucose absorption and second to restore the gut-brain axis to treat insulin resistance. This evidence concerns the gene SLC2A2 and Hyperglycemia.